Innova
Rx
Innova Health Strategies
Search
Index
Browse
Meds
Risk score
Pricing
Sign in
Code set
FY2027
FY2026
FY2025
FY2024
Go
Light
System
Dark
/
Medications
›
dacarbazine
dacarbazine
RxCUI 3098
ingredient
Contraindicated with · 5
Chemically-Induced Disorders
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Drug Hypersensitivity
Drug-Related Side Effects and Adverse Reactions
Indicated for · 46
Adenocarcinoma
Carcinoma
Carcinoma, Islet Cell
Carcinoma, Medullary
Carcinoma, Neuroendocrine
Digestive System Diseases
Digestive System Neoplasms
Disease
Diseases, Life Phases, Behavior Mechanisms and Physiologic States
Endocrine Gland Neoplasms
Endocrine System Diseases
Fibrosarcoma
Hemic and Lymphatic Diseases
Hodgkin Disease
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma
Lymphoproliferative Disorders
Melanoma
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Ductal, Lobular, and Medullary
Neoplasms, Fibrous Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroblastoma
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Neuroendocrine Tumors
Nevi and Melanomas
Pancreatic Diseases
Pancreatic Neoplasms
Rhabdomyosarcoma
Sarcoma
Skin and Connective Tissue Diseases
Skin Diseases
Skin Neoplasms